Original Research
Accepted on 18 Feb 2026
Analysis of Risk Factors for Relapse in Pediatric MOG Antibody-Associated Disease: A Single-Center Retrospective Cohort Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Type at least 3 characters
1,194 articles
articles
Review
Accepted on 18 Feb 2026
The glia-neutrophil axis: An understudied crosstalk in bacteria-induced neuroinflammation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Editorial
Published on 18 Feb 2026
Editorial: Reviews in: multiple sclerosis and neuroimmunology
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1746702
- 250 views
Mini Review
Accepted on 12 Feb 2026
Increasing the rigor of body composition and adiposity measurement in multiple sclerosis research
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 184 views
Original Research
Published on 11 Feb 2026
Machine learning and single-cell RNA sequencing analyses identify MS-related monocytes and a five-gene candidate biomarker signature
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1739231
- 425 views
Review
Accepted on 09 Feb 2026
Interaction of brain endothelial cells with T cells: implications for progression and therapeutic strategies of multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Original Research
Accepted on 09 Feb 2026
Seizures as the Initial Manifestation: Characterizing the Adult Phenotype of MOG Antibody-Associated Disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Original Research
Published on 09 Feb 2026
Analysis of the incidence status and risk factors for immune-mediated neuropathies: a single-center case–control study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1733557
- 266 views
Original Research
Published on 04 Feb 2026
Serum neurofilament light chain and disease-modifying treatment as predictors of cognitive decline in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1743472
- 419 views
Original Research
Accepted on 02 Feb 2026
The Lithuanian multiple sclerosis registry: current framework and quality challenges
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Original Research
Published on 30 Jan 2026
Predictors of initiating high-efficacy vs. platform therapies as first-line disease-modifying treatment in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1738815
- 1,509 views
Original Research
Published on 28 Jan 2026
Neutrophil-to-apolipoprotein A1 ratio as a novel biomarker for prognosis in anti-NMDAR encephalitis: a retrospective cohort analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1725493
- 362 views
Review
Accepted on 27 Jan 2026
Enhancing the Endocannabinoid System to treat residual disease in Relapse-Free Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 236 views
Original Research
Published on 27 Jan 2026
Clinical characteristics of MOG antibody-positive anti-NMDAR encephalitis: a single-center retrospective study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1742531
- 525 views
Original Research
Published on 26 Jan 2026
Experience of using anti-CD 20 therapies in multiple sclerosis patients in Kenya
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1681527
- 617 views
Original Research
Published on 20 Jan 2026
Differential diagnosis between NMOSD and MS: a retrospective study based on clinical and imaging features
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1718736
- 961 views
Systematic Review
Published on 19 Jan 2026
The effects of fampridine on MS-related fatigue: a systematic review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1720316
- 655 views
Original Research
Accepted on 13 Jan 2026
Multimodal MRI Assessment of Neuroprotective Effects of Ofatumumab on Brain Structure, Function, and Clinical Correlates in Relapsing Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 183 views
Opinion
Published on 08 Jan 2026
Plasma exchange following immunoglobulins for Guillain-Barré-Syndrome: a persisting problematic practice?
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1712202
- 1,953 views
Original Research
Published on 08 Jan 2026
Add-on efgartigimod in myasthenic crisis: a promising treatment option
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1696976
- 1,038 views
Original Research
Published on 05 Jan 2026
NEDA-3 using cladribine for multiple sclerosis: effectiveness data from a Norwegian hospital
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1698334
- 1,689 views
Systematic Review
Published on 02 Jan 2026
Vitamin D deficiency and multiple sclerosis relapse: a meta-analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1727615
- 1,519 views
Original Research
Accepted on 29 Dec 2025
B-cell Immune Repertoire analysis of autoimmune neurological syndrome with anti-GAD65 antibodies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 174 views
Original Research
Published on 15 Dec 2025
Anti-LGI1 encephalitis: clinical presentation, imaging features, and prognostic analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1703647
- 1,644 views